/BAX
Baxter International Inc.
BAX • NYSEBAX • NYSE • Healthcare
$18.01-0.22%-0.04
$18.01-0.22%(-0.04)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
92Bullish
Risk
98Low Risk
Momentum
5Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
30.1%▼7.4pp
Revenue after COGS
Operating
-2.7%▼2.9pp
After operating expenses
Net
-8.5%▼2.4pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
-10.2
Price vs earnings
EV/EBITDA
23.3
Enterprise value
FCF Yield
3.3%
Cash generation
Earnings Yield
-9.8%
Inverse of P/E
Capital Efficiency
-7
GoAI Quality ScorePoor
ROEReturn on Equity
-15.6%Weak
ROAReturn on Assets
-4.8%Weak
ROICReturn on Invested Capital
-1.8%Weak
Financial Health
Current RatioHealthy
2.31
Short-term solvency (>1.5)
Net Debt / EBITDAHigh
10.49x
Debt repayment capacity (<3x)
Income QualityWeak
-0.88
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $11.24B | $10.64B | $10.36B | $10.06B | $12.15B |
| Gross Profit | $3.38B | $3.98B | $4.15B | $3.55B | $4.72B |
| Gross Margin | 30.1% | 37.5% | 40.1% | 35.3% | 38.9% |
| Operating Income | -$308.00M | $14.00M | $707.00M | -$2.85B | $1.35B |
| Net Income | -$957.00M | -$649.00M | $2.66B | -$2.43B | $1.28B |
| Net Margin | -8.5% | -6.1% | 25.6% | -24.2% | 10.6% |
| EPS | -$1.75 | -$1.27 | $5.25 | -$4.83 | $2.56 |
Average Price Target
$19.75▲ 9.7% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Baxter International Inc., the average price target is $19.75, with a high forecast of $25.00 and a low forecast of $15.00. The average price target represents a 9.7% increase from the current price of $18.01.
Highest
$25.00
Average
$19.75
Lowest
$15.00
Rating Distribution
Strong Buy
0
0%
Buy
15
42%
Hold
20
56%
Sell
1
3%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Citigroup● Maintain
Neutral
2026-03-11Goldman Sachs● Maintain
Neutral
2026-02-17Barclays● Maintain
Overweight
2026-02-13Barclays● Maintain
Overweight
2026-01-09Morgan Stanley● Maintain
Underweight
2025-12-02Goldman Sachs● Maintain
Neutral
2025-10-31Argus Research▼ Downgrade
Buy→Hold
2025-10-31Citigroup● Maintain
Neutral
2025-10-31UBS● Maintain
Neutral
2025-10-31Evercore ISI Group● Maintain
Outperform
2025-10-07Earnings History & Surprises
BEAT RATE
67%
Last 18 quarters
AVG SURPRISE
+3.9%
EPS vs Estimate
BEATS / MISSES
12/5
1 met exactly
LATEST EPS
$0.44
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
-17.9%
$0.44 vs $0.54
Q4 '25
+15.0%
$0.69 vs $0.60
Q3 '25
-1.7%
$0.59 vs $0.60
Q2 '25
+13.8%
$0.55 vs $0.48
Q1 '25
+9.8%
$0.58 vs $0.53
Q4 '24
+2.6%
$0.80 vs $0.78
Q3 '24
+2.7%
$0.68 vs $0.66
Q2 '24
+7.1%
$0.65 vs $0.61
Q1 '24
+2.3%
$0.88 vs $0.86
Q4 '23
+3.0%
$0.68 vs $0.66
Q3 '23
-6.8%
$0.55 vs $0.59
Q2 '23
+22.9%
$0.59 vs $0.48
No investor questions available.
Latest News
No news available